474
Views
15
CrossRef citations to date
0
Altmetric
Reviews

Add-on therapies to metformin for type 2 diabetes

, MD CM
Pages 47-62 | Published online: 10 Dec 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Elisa Guarino, Laura Nigi, Aurora Patti, Cecilia Fondelli & Francesco Dotta. (2012) Combination therapy with metformin plus vildagliptin in type 2 diabetes mellitus. Expert Opinion on Pharmacotherapy 13:9, pages 1377-1384.
Read now
André J Scheen. (2012) Metformin + saxagliptin for type 2 diabetes. Expert Opinion on Pharmacotherapy 13:1, pages 139-146.
Read now

Articles from other publishers (10)

Xueling Liao, Yan Zhu & Chao Xue. (2022) Diagnostic value of serum cystatin C for diabetic nephropathy: a meta-analysis. BMC Endocrine Disorders 22:1.
Crossref
Tejas Wattamwar, Ashish Mungantiwar, Supriya Gujar & Nancy Pandita. (2020) Development of LC-MS/MS method for simultaneous determination of Canagliflozin and Metformin in human plasma and its pharmacokinetic application in Indian population under fast and fed conditions. Journal of Chromatography B 1154, pages 122281.
Crossref
Tejas Wattamwar, Ashish Mungantiwar, Supriya Halde & Nancy Pandita. (2019) Development of simultaneous determination of empagliflozin and metformin in human plasma using liquid chromatography–mass spectrometry and application to pharmacokinetics. European Journal of Mass Spectrometry 26:2, pages 117-130.
Crossref
Daisuke Yabe, Anu Ambos, Bertrand Cariou, Lea Duvnjak, Marc Evans, Guillermo González-Gálvez, Jay Lin, Elena V. Nikonova, Pedro de Pablos-Velasco, Jean-François Yale & Bo Ahrén. (2016) Efficacy of lixisenatide in patients with type 2 diabetes: A post hoc analysis of patients with diverse β-cell function in the GetGoal-M and GetGoal-S trials. Journal of Diabetes and its Complications 30:7, pages 1385-1392.
Crossref
Philip A. Levin, Steve Zhou, Jasvinder Gill & Wenhui Wei. (2015) Health Outcomes Associated with Initiation of Basal Insulin After 1, 2, or ≥ 3 Oral Antidiabetes Drug(s) Among Managed Care Patients with Type 2 Diabetes. Journal of Managed Care & Specialty Pharmacy 21:12, pages 1172-1182.
Crossref
Qiao Li, Lie Feng, Jiaying Li & Qianqian Chen. (2013) Urinary Smad1 is a new biomarker for diagnosis and evaluating the severity of diabetic nephropathy. Endocrine 46:1, pages 83-89.
Crossref
Thundiparambil Azeez Sonia & Chandra P. Sharma. 2014. Oral Delivery of Insulin. Oral Delivery of Insulin 1 57 .
James W. Little, Donald A. Falace, Craig S. Miller & Nelson L. Rhodus. 2013. Little and Falace's Dental Management of the Medically Compromised Patient. Little and Falace's Dental Management of the Medically Compromised Patient 219 239 .
Jin Ah Jung, Jung-Ryul Kim, Suk-Ran Kim, Tae-Eun Kim, Soo-Youn Lee, Jae-Wook Ko & Wooseong Huh. (2012) Pharmacokinetics of a Fixed-Dose Combination of Mitiglinide and Metformin versus Concurrent Administration of Individual Formulations in Healthy Subjects. Clinical Drug Investigation 32:12, pages 799-804.
Crossref
Timothy Colin Hardman & Simon William Dubrey. (2011) Development and potential role of type-2 sodium-glucose transporter inhibitors for management of type 2 diabetes. Diabetes Therapy 2:3, pages 133-145.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.